SANTA CLARA, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV) (“Shockwave Medical”) announced today the pricing of its offering of $650.0 million aggregate principal ...

SANTA CLARA, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV) (“Shockwave Medical”) announced today that it intends to offer, subject to market conditions and other ...

Shockwave shares are trading higher Tuesday following a report suggesting Johnson & Johnson is in talks to acquire the company. People familiar with the matter say that a deal to acquire the company ...

ShockWave Medical, Inc. SWAV is well-poised for growth, backed by its research and development (R&D) efforts, and its focus on clinical studies. Shares of this presently Zacks Rank #2 (Buy) player ...

As we move towards year-end 2023, I am assembling a list of potential healthcare tickers that are worthy of consideration for a spot in one of my three healthcare portfolios (speculative, growth, ...

Shares of Shockwave Medical SWAV are up almost 15% so far this week. Majority of this gain is likely due to acquisition rumors. According to a report by the Wall Street Journal, Johnson & Johnson JNJ ...

ShockWave’s disruptive approach within the calcified cardiovascular disease space creates a first-mover advantage offering the opportunity of robust sales growth. ShockWave Medical’s business model ...

In a deal that might as well be termed a heart-to-heart, Shockwave Medical has made a bid to combine Neovasc’s cardiac device business with its own. Shockwave has offered up $27.25 in upfront cash for ...

(Bloomberg) -- Johnson & Johnson agreed to acquire Shockwave Medical Inc. for about $13.1 billion to bolster its expansion into making medical devices to treat heart disease. J&J will pay $335 a share ...

FREMONT, Calif.--(BUSINESS WIRE)--Shockwave Medical, a pioneer in the treatment of advanced peripheral and coronary vascular disease, today announced CE Mark regulatory approval for the company’s ...